
March 2025 — CDMO Opportunities And Threats Report
Contractor BioPharma Company Event Product Relationship POTENTIALLY POSITIVE AbbVie Inc AstraZeneca UK Ltd NICE recommended the drug, within its marketing authorisation, as an option for treating HER2-negative locally advanced or metastatic breast cancer …